StockNews.com began coverage on shares of Oxbridge Re (NASDAQ:OXBR – Free Report) in a report published on Thursday morning. The brokerage issued a hold rating on the insurance provider’s stock.
Oxbridge Re Trading Down 0.4 %
OXBR stock opened at $2.79 on Thursday. The business’s fifty day moving average price is $2.51 and its 200 day moving average price is $2.00. Oxbridge Re has a 12-month low of $0.87 and a 12-month high of $3.72.
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last issued its earnings results on Thursday, August 8th. The insurance provider reported ($0.14) earnings per share (EPS) for the quarter. The firm had revenue of $0.04 million during the quarter.
Insider Buying and Selling at Oxbridge Re
Institutional Investors Weigh In On Oxbridge Re
A hedge fund recently raised its stake in Oxbridge Re stock. Henrickson Nauta Wealth Advisors Inc. increased its position in shares of Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) by 50.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,000 shares of the insurance provider’s stock after buying an additional 5,000 shares during the quarter. Henrickson Nauta Wealth Advisors Inc. owned 0.25% of Oxbridge Re worth $36,000 at the end of the most recent quarter. 5.64% of the stock is owned by institutional investors and hedge funds.
About Oxbridge Re
Oxbridge Re Holdings Limited, through its subsidiaries, provides specialty property and casualty reinsurance solutions. The company underwrites collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. It also issues reinsurance contracts through digital securities by blockchain technology.
Further Reading
- Five stocks we like better than Oxbridge Re
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Consumer Discretionary Stocks Explained
- MarketBeat Week in Review – 9/23 – 9/27
- How to Calculate Stock Profit
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.